Centene Corporation (CNC): Price and Financial Metrics
Centene Corporation (CNC)
Today's Latest Price: $56.30 USD
Updated Apr 2 12:21pm
Add CNC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 9 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
CNC Stock Summary
- CNC has a market capitalization of $28,593,251,275 -- more than approximately 94.96% of US stocks.
- The capital turnover (annual revenue relative to shareholder's equity) for CNC is 5.95 -- better than 93.65% of US stocks.
- With a year-over-year growth in debt of 105.29%, Centene Corp's debt growth rate surpasses 86.5% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Centene Corp are HUM, HSY, EMR, ROST, and GIS.
- Visit CNC's SEC page to see the company's official filings. To visit the company's web site, go to www.centene.com.
CNC Stock Price Chart More Charts
CNC Price/Volume Stats
| Current price | $56.30 | 52-week high | $68.64 |
| Prev. close | $56.12 | 52-week low | $41.62 |
| Day low | $54.02 | Volume | 1,117,011 |
| Day high | $57.46 | Avg. volume | 6,557,944 |
| 50-day MA | $59.57 | Dividend yield | N/A |
| 200-day MA | $54.48 | Market Cap | 33.04B |
Centene Corporation (CNC) Company Bio
Centene Corporation provides a portfolio of services to government-sponsored healthcare programs, focusing on under-insured and uninsured individuals. The company was founded in 1984 and is based in St. Louis, Missouri.
CNC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $56.30 | $24.33 | -57% |
We started the process of determining a valid price forecast for Centene Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Centene Corp ranked in the 21th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 56.33%. As for the metrics that stood out in our discounted cash flow analysis of Centene Corp, consider:
- The company's balance sheet shows it gets 63% of its capital from equity, and 37% of its capital from debt. Notably, its equity weight is greater than only 23.64% of US equities in the Healthcare sector yielding a positive free cash flow.
- Centene Corp's weighted average cost of capital (WACC) is 6%; for context, that number is higher than just 15.05% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -57% |
| 1% | -57% |
| 2% | -57% |
| 3% | -56% |
| 4% | -56% |
| 5% | -55% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CNC, try CAH, NRC, MTD, HAE, and HOLX.
Loading social stream, please wait...